Kadowaki D - Search Results

1

Olmesartan protects endothelial cells against oxidative stress-mediated cellular injury.

Kadowaki D, Anraku M, Sakaya M, Hirata S, Maruyama T, Otagiri M. Kadowaki D, et al. Clin Exp Nephrol. 2015 Dec;19(6):1007-14. doi: 10.1007/s10157-015-1111-5. Epub 2015 Apr 23. Clin Exp Nephrol. 2015. PMID: 25904217

2

Effect of olmesartan on oxidative stress in hemodialysis patients.

Kadowaki D, Anraku M, Tasaki Y, Kitamura K, Wakamatsu S, Tomita K, Gebicki JM, Maruyama T, Otagiri M. Kadowaki D, et al. Hypertens Res. 2007 May;30(5):395-402. doi: 10.1291/hypres.30.395. Hypertens Res. 2007. PMID: 17587751 Clinical Trial.

3

Alpha1-acid glycoprotein suppresses rat acute inflammatory paw edema through the inhibition of neutrophils activation and prostaglandin E2 generation.

Matsumoto K, Nishi K, Kikuchi M, Kadowaki D, Tokutomi Y, Tokutomi N, Nishi K, Suenaga A, Otagiri M. Matsumoto K, et al. Among authors: kadowaki d. Biol Pharm Bull. 2007 Jul;30(7):1226-30. doi: 10.1248/bpb.30.1226. Biol Pharm Bull. 2007. PMID: 17603158 Free article.

4

Effect of famotidine and lansoprazole on serum phosphorus levels in hemodialysis patients on calcium carbonate therapy.

Matsunaga C, Izumi S, Furukubo T, Satoh M, Yamakawa T, Uchida T, Kadowaki D, Hirata S. Matsunaga C, et al. Among authors: kadowaki d. Clin Nephrol. 2007 Aug;68(2):93-8. doi: 10.5414/cnp68093. Clin Nephrol. 2007. PMID: 17722708

5

Antioxidant effects of a dietary supplement: reduction of indices of oxidative stress in normal subjects by water-soluble chitosan.

Anraku M, Fujii T, Furutani N, Kadowaki D, Maruyama T, Otagiri M, Gebicki JM, Tomida H. Anraku M, et al. Among authors: kadowaki d. Food Chem Toxicol. 2009 Jan;47(1):104-9. doi: 10.1016/j.fct.2008.10.015. Epub 2008 Oct 22. Food Chem Toxicol. 2009. PMID: 18996432 Clinical Trial.

6

[To facilitate the compliance of phosphate binder for the control of hyperphosphatemia in chronic kidney disease patients].

Maruyama T, Kadowaki D. Maruyama T, et al. Among authors: kadowaki d. Clin Calcium. 2009 Feb;19(2):248-52. Clin Calcium. 2009. PMID: 19182367 Review. Japanese.

7

A site-directed mutagenesis study of drug-binding selectivity in genetic variants of human alpha(1)-acid glycoprotein.

Nishi K, Ueno M, Murakami Y, Fukunaga N, Akuta T, Kadowaki D, Watanabe H, Suenaga A, Maruyama T, Otagiri M. Nishi K, et al. Among authors: kadowaki d. J Pharm Sci. 2009 Nov;98(11):4316-26. doi: 10.1002/jps.21697. J Pharm Sci. 2009. PMID: 19198000

8

Hemoglobin vesicles, polyethylene glycol (PEG)ylated liposomes developed as a red blood cell substitute, do not induce the accelerated blood clearance phenomenon in mice.

Taguchi K, Urata Y, Anraku M, Watanabe H, Kadowaki D, Sakai H, Horinouchi H, Kobayashi K, Tsuchida E, Maruyama T, Otagiri M. Taguchi K, et al. Among authors: kadowaki d. Drug Metab Dispos. 2009 Nov;37(11):2197-203. doi: 10.1124/dmd.109.028852. Epub 2009 Aug 13. Drug Metab Dispos. 2009. PMID: 19679674

9

Evaluation for antioxidant and renoprotective activity of olmesartan using nephrectomy rats.

Kadowaki D, Anraku M, Tasaki Y, Taguchi K, Shimoishi K, Seo H, Hirata S, Maruyama T, Otagiri M. Kadowaki D, et al. Biol Pharm Bull. 2009 Dec;32(12):2041-5. doi: 10.1248/bpb.32.2041. Biol Pharm Bull. 2009. PMID: 19952425 Free article.

10

Receptor-mediated uptake of human alpha1-acid glycoprotein into liver parenchymal cells in mice.

Matsumoto K, Nishi K, Kikuchi M, Watanabe H, Nakajou K, Komori H, Kadowaki D, Suenaga A, Maruyama T, Otagiri M. Matsumoto K, et al. Among authors: kadowaki d. Drug Metab Pharmacokinet. 2010;25(1):101-7. doi: 10.2133/dmpk.25.101. Drug Metab Pharmacokinet. 2010. PMID: 20208393 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

79 results

Search Page

Filters